Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (FRA:GU5)

FRA:GU5 Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,748	5,785	5,684	6,289	7,212	5,590
Market Cap Growth	-15.21%	1.78%	-9.62%	-12.80%	29.01%	-21.00%
Enterprise Value	4,729	5,569	4,927	5,206	5,672	4,534
Last Close Price	1.97	2.04	2.14	2.28	1.91	1.51
PE Ratio	13.28	15.42	10.99	11.69	14.01	15.31
PS Ratio	0.51	0.58	0.59	0.66	0.76	0.72
PB Ratio	0.99	1.16	1.22	1.38	1.66	1.58
P/TBV Ratio	1.16	1.36	1.43	1.62	2.03	1.95
P/FCF Ratio	39.80	18.89	18.00	8.26	11.79	-
P/OCF Ratio	17.85	12.70	10.86	6.62	9.18	76.29
EV/Sales Ratio	0.50	0.56	0.51	0.54	0.59	0.59
EV/EBITDA Ratio	8.70	10.34	7.07	7.67	9.33	10.60
EV/EBIT Ratio	10.53	12.11	8.05	8.55	10.32	11.96
EV/FCF Ratio	39.64	18.18	15.60	6.84	9.27	-
Debt / Equity Ratio	0.40	0.37	0.33	0.36	0.32	0.34
Debt / EBITDA Ratio	3.59	3.23	2.09	2.30	2.14	2.60
Debt / FCF Ratio	16.16	6.01	4.83	2.14	2.25	-
Asset Turnover	0.96	0.94	0.99	1.01	1.10	1.06
Inventory Turnover	5.77	5.14	5.53	5.45	5.53	5.33
Quick Ratio	1.15	1.11	1.17	1.20	1.27	1.23
Current Ratio	1.60	1.48	1.55	1.53	1.64	1.62
Return on Equity (ROE)	7.97%	8.06%	12.12%	13.09%	13.33%	11.41%
Return on Assets (ROA)	2.85%	2.71%	3.91%	3.98%	3.94%	3.24%
Return on Invested Capital (ROIC)	8.39%	10.41%	16.80%	18.98%	17.98%	15.46%
Return on Capital Employed (ROCE)	8.20%	8.10%	11.30%	12.00%	11.70%	9.90%
Earnings Yield	7.53%	6.49%	9.10%	8.56%	7.14%	6.53%
FCF Yield	2.51%	5.29%	5.56%	12.11%	8.48%	-0.65%
Dividend Yield	4.85%	5.20%	4.46%	4.36%	4.97%	4.45%
Payout Ratio	77.85%	79.38%	39.09%	37.58%	34.03%	44.25%
Buyback Yield / Dilution	-0.01%	-0.02%	0.02%	-	-	-
Total Shareholder Return	4.83%	5.18%	4.47%	4.36%	4.97%	4.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.